<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00265902</url>
  </required_header>
  <id_info>
    <org_study_id>J0429</org_study_id>
    <secondary_id>CDR0000452799</secondary_id>
    <secondary_id>JHOC-0429</secondary_id>
    <secondary_id>04-08-06-02</secondary_id>
    <nct_id>NCT00265902</nct_id>
  </id_info>
  <brief_title>Infrared Thermography in Finding Skin Lesions in Patients With Kaposi's Sarcoma</brief_title>
  <official_title>Ultra-Sensitive, Infra-Red Thermographic Analysis of Kaposi's Sarcoma Skin Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins</source>
  <brief_summary>
    <textblock>
      RATIONALE: Diagnostic procedures, such as infrared thermography, may help find Kaposi's&#xD;
      sarcoma and learn the extent of disease.&#xD;
&#xD;
      PURPOSE: This clinical trial is studying how well infrared thermography finds skin lesions in&#xD;
      patients with Kaposi's sarcoma.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:&#xD;
&#xD;
      Primary&#xD;
&#xD;
        -  Compare ultra-sensitive infrared thermographic images with visible light digital&#xD;
           photographic images and clinical dermatologic examination as methods of measuring&#xD;
           cutaneous lesions in patients with Kaposi's sarcoma (KS).&#xD;
&#xD;
      Secondary&#xD;
&#xD;
        -  Compare differences in modulation of temperature detected in KS skin lesions with&#xD;
           non-involved skin of the same patient and with normal skin of healthy volunteers by&#xD;
           sequential imaging using the infrared thermographic camera.&#xD;
&#xD;
      OUTLINE: This is a controlled, pilot study.&#xD;
&#xD;
      Patients undergo clinical assessment followed by simultaneous digital photographic camera&#xD;
      imaging and high-resolution infrared thermographic camera imaging of designated normal skin&#xD;
      areas and selected marker lesions. Before imaging, a metal bar chilled to 0ยบ C, 10ยบ C, and&#xD;
      25ยบ C is applied to the lesions and designated normal skin areas for up to 90 seconds.&#xD;
&#xD;
      Healthy volunteers (controls) undergo the same procedure as for the patient except only&#xD;
      designated normal skin areas are used.&#xD;
&#xD;
      PROJECTED ACCRUAL: A total of 20 patients and 10 healthy volunteers (controls) will be&#xD;
      accrued for this study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    low accrual&#xD;
  </why_stopped>
  <start_date type="Actual">October 3, 2005</start_date>
  <completion_date type="Actual">March 21, 2006</completion_date>
  <primary_completion_date type="Actual">March 21, 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Diagnostic</primary_purpose>
  </study_design_info>
  <enrollment type="Actual">3</enrollment>
  <condition>Sarcoma</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>diagnostic imaging</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:&#xD;
&#xD;
          -  Meets 1 of the following criteria:&#xD;
&#xD;
               -  Histologically confirmed cutaneous Kaposi's sarcoma (KS)&#xD;
&#xD;
                    -  At least one skin lesion accessible for imaging&#xD;
&#xD;
                    -  HIV positivity with proven cutaneous KS and concurrent visceral or mucous&#xD;
                       membrane involvement allowed&#xD;
&#xD;
               -  Healthy volunteer (regardless of HIV status) (control)&#xD;
&#xD;
        PATIENT CHARACTERISTICS:&#xD;
&#xD;
        Performance status&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Life expectancy&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Hematopoietic&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Hepatic&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Renal&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Other&#xD;
&#xD;
          -  Pregnancy allowed&#xD;
&#xD;
        PRIOR CONCURRENT THERAPY:&#xD;
&#xD;
          -  Prior topical, intralesional, or systemic treatment allowed&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>120 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ciro Martins, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21231-2410</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2006</verification_date>
  <study_first_submitted>December 14, 2005</study_first_submitted>
  <study_first_submitted_qc>December 14, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 15, 2005</study_first_posted>
  <last_update_submitted>March 18, 2019</last_update_submitted>
  <last_update_submitted_qc>March 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Kaposi sarcoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcoma, Kaposi</mesh_term>
    <mesh_term>Sarcoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

